Impaired cyclic AMP production in the hippocampus of a Down syndrome murine model

Developmental Brain Research

Volumn 95, Issue 1, 1996, Pages 122-124

  Dierssen, Mara ^a   Vallina, Iria F ^a   Baamonde, Carmela ^a   Lumbreras, María A ^a   Martínez Cué, Carmen ^a   Calatayud, Salvador G ^a   Flórez, Jesús ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Cyclic AMP; Down syndrome; Hippocampus; Partial trisomy 16

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYCLIC AMP; FORSKOLIN; ISOPRENALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; HIPPOCAMPUS; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; TRISOMY;

EID: 0030595010     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-3806(96)00071-5     Document Type: Article

References (13)

1. [1] Brown, B.L., Albano, J.D.M., Elkins, R.P. and Sgherzi, A.M., A simple and sensitive assay method for the measurement of adenosine 3′,5′-cyclic monophosphate, Biochem. J., 121 (1971) 561-562.
2. [2] Byrne, J.H., Zwarties, R., Homayouni, R., Critz, S.D. and Eskin, A., Roles of second messenger pathways in neuronal plasticity and in learning and memory. Insights gained from Aplysia. In: S. Shenolikar and A.C. Nairm (Eds.), Advances in Second Messenger and Phosphoprotein Research, Raven Press, New York, 1993, pp. 47-108.
3. [3] Coussons-Read, M.E. and Crnic, L.S., Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: Altered behavior in the elevated plus maze and the open field, Behav. Genet., 26 (1996) 7-13.
4. [4] Davisson, M.T., Schmidt, C., Reeves, R.H., Irving, N.G., Akeson, E.G., Harris, B.S. and Bronson, R.T., Segmental trisomy as a mouse model for Down syndrome. In: C.J. Epstein (Ed.), The Phenotypic Mapping of Down Syndrome and Other Aneuploid Conditions, Wiley-Liss, New York, 1993, pp. 117-133.
5. [5] Eichenbaum, H., Otto, T. and Cohen, N.J., Two functional components of the hippocampal memory system, Behav. Brain Sci., 17 (1994) 449-518.
6. [6] Epstein, C.J., Cox, D.R. and Epstein, L.B., Mouse trisomy 16: an animal model for trisomy 21 (Down's syndrome), Ann. NY Acad. Sci., 450 (1985) 157-177.
7. [7] Escorihuela, R.M., Fernández-Teruel, A., Vallina, I.F., Baamonde, C., Lumbreras, M.A., Dierssen, M., Tobeña, A. and Flörez, J. A behavioral assessment of Ts65Dn mice: a putative Down syndrome model, Neurosci. Lett., 199 (1995) 143-146.
8. [8] Hunter, A. and Steward, M.G., Long-term increases in the numerical density of synapses in the chick lobus paraolfactorius after passive avoidance training, Brain Res., 605 (1993) 251-255.
9. [9] McSwigan, J.D., Hanson, D.R., Lubiniecki, A., Heston, L.L. and Sheppard, J.R., Down syndrome fibroblasts are hyperresponsive to β-adrenergic stimulation, Proc. Natl. Acad. Sci. USA, 78 (1981) 7670-7673.
10. [10] Reeves, R.H., Irving, N.G., Moran, T.H., Wohn, A., Kitt, C., Sisodia, S.S., Schmidt, C., Bronson, R.T. and Davisson, M.T., A mouse model for Down syndrome exhibits learning and behaviour deficits, Nature Genet., 11 (1995) 177-184.
11. [11] Riolobos, A.S., Criado, J.M., de la Fuente, A. and Yajeya, J., Changes in the unitary activity in the basolateral amygdaloid nucleus of the rat after the application of a foot-shock, Neurosci. Res. Commun., 12 (1993) 93-101.
12. [12] Tovey, K.C., Oldham, K.G. and Whelan, J.M.A., A single direct assay for cyclic AMP in plasma and other biological samples using an improved competitive binding technique, Clin. Chem. Acta, 56 (1974) 221.
13. [13] Uecker, A., Mangan, P.A., Obrzut, J.E. and Nadel, L., Down syndrome in neurobiological perspective: An emphasis on spatial cognition, J. Clin. Child Physiol., 26 (1993) 266-276.